2% Xylocaine DENTAL with Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose cartridges, 1.7 mL each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-176-16.
Published December 24, 2025 · Recall initiated: October 31, 2025
Summary
FDA records drug Class II recall D-0228-2026, published December 24, 2025 and initiated October 31, 2025. Recalling firm: Novocol Pharmaceutical of Canada, Inc.; Status: Ongoing; Reported quantity: 18,789 cartons- 50 cartridges /carton; Lot: Lot: D05337B, expires: 06-30-2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective container: cracked/broken cartridges
What to do
Voluntary: Firm initiated · Letter
Get an email if XYLOCAINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- XYLOCAINE
- Manufacturer
- Novocol Pharmaceutical of Canada, Inc.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot: D05337B, expires: 06-30-2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDAXylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL,July 29, 2026
- FDAXylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL,July 29, 2026
- FDALidocaine HCI 2% and Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a cartonDecember 24, 2025
- FDACardiosave Rescue. Intra-Aortic Balloon Pump system.December 17, 2025
- FDAXylocaine + Epinephrine, multi dose vial 2%, 20 mL, 25 count box, Rx only, MFG: Fresenius Kabi USA LLC, NDCJune 15, 2022
- FDAXylocaine + Epinephrine, multi dose vial 1%, packaged in a) 20 mL, 25-count box (NDC 63323-482-27) b) 50 mL,June 15, 2022
Questions about this recall
Was 2% Xylocaine DENTAL with Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose cartridges, 1.7 mL each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-176-16. recalled?
Yes. FDA published recall D-0228-2026 on December 24, 2025. Reported hazard: Defective container: cracked/broken cartridges
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: XYLOCAINE.